Dichloromethane → HCID 22396903, compound
Reaction equation
[NH:1]1[C:5]2[CH:6]=[CH:7][CH:8]=[CH:9][C:4]=2[N:3]=[C:2]1[CH2:10][N:11]1[C:19]2[CH:18]=[CH:17][CH:16]=[C:15]([Br:20])[C:14]=2[C:13]2[CH2:21][CH2:22][N:23](C(OC(C)(C)C)=O)[CH2:24][CH2:25][C:12]1=2.FC(F)(F)C(O)=O.C(Cl)[Cl:41]>>[ClH:41].[NH:1]1[C:5]2[CH:6]=[CH:7][CH:8]=[CH:9][C:4]=2[N:3]=[C:2]1[CH2:10][N:11]1[C:19]2[CH:18]=[CH:17][CH:16]=[C:15]([Br:20])[C:14]=2[C:13]2[CH2:21][CH2:22][NH:23][CH2:24][CH2:25][C:12]1=2Participants
Procedure
tert-Butyl 6-(1H-benzimidazol-2-ylmethyl)-10-bromo-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate (0.105 g, 0.212 mmol) was dissolved in CH2Cl2 (5 mL) and trifluoroacetic acid (2.0 mL, 2.96 g, 26.0 mmol, 122 equiv.) was added. This mixture was stirred at rt in a capped vessel for 2.5 h. The reaction mixture was concentrated to dryness. The residue was taken up in EtOAc (2 mL), and 1M HCl in Et2O was added. The hydrochloride salt was collected by filtration and dried under vacuum. 6-(1H-benzimidazol-2-ylmethyl)-10-bromo-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole hydrochloride (0.943 g) was produced in quantitative yield. 1H NMR (300 MHz, DMF) δ 3.61-3.70, 3.83-3.86, 6.12, 7.06, 7.31, 7.36-7.42, 7.66-7.74, 7.74; 1H NMR (300 MHz, CD3OD) δ 3.33-3.36, 3.54-3.59, 3.83-3.86, 6.04, 7.09, 7.35, 7.41, 7.54-7.57, 7.71-7.74; MS (ESI+) for C20H19BrN4 m/z 395, 396.9 (M+H)+.
Workup
- concentrationThe reaction mixture was concentrated to dryness
- addition1M HCl in Et2O was added
- filtrationThe hydrochloride salt was collected by filtration
- customdried under vacuum
Sources & evidence
- ORD record
- ord-cc46bd59504440659154cf3ca001464d
- Source dataset
- uspto-grants-2003_07
- Patent number
- US06586421B2
Reaction notes
Loading…